Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferdeghini

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Anticancer Research|September 1, 1993
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervixM Ferdeghini, A Gadducci, C Annicchiarico, et al.
The Journal of Nuclear Medicine and Allied Sciences|July 1, 1981
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical trainingA Clerico, M Ferdeghini, C Palombo, et al.
European Journal of Gynaecological Oncology|June 26, 1998
Stress and cervical dysplasiaC De Punzio, C Salvestroni, G Guazzelli, et al.
Anticancer Research|November 1, 1996
Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancerA Gadducci, M Ferdeghini, F Buttitta, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1988
Relationship between pain sensitivity, cardiovascular reactivity to cold pressor test and indexes of activity of the adrenergic and opioid systemC Rosa, S Ghione, L Mezzasalma, et al.
Anticancer Research|September 1, 1996
Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancerA Gadducci, M Ferdeghini, A Fanucchi, et al.
Anticancer Research|March 12, 1998
Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, A Fanucchi, et al.
Anticancer Research|May 6, 1998
The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancerA Gadducci, M Ferdeghini, S Cosio, et al.
Clinical Endocrinology|June 9, 2007
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancerA Iervasi, G Iervasi, M Ferdeghini, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1987
Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patientsO Giampietro, M Ferdeghini, R Miccoli, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Anticancer Research|September 1, 1993
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervixM Ferdeghini, A Gadducci, C Annicchiarico, et al.
The Journal of Nuclear Medicine and Allied Sciences|July 1, 1981
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical trainingA Clerico, M Ferdeghini, C Palombo, et al.
European Journal of Gynaecological Oncology|June 26, 1998
Stress and cervical dysplasiaC De Punzio, C Salvestroni, G Guazzelli, et al.
Anticancer Research|November 1, 1996
Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancerA Gadducci, M Ferdeghini, F Buttitta, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1988
Relationship between pain sensitivity, cardiovascular reactivity to cold pressor test and indexes of activity of the adrenergic and opioid systemC Rosa, S Ghione, L Mezzasalma, et al.
Anticancer Research|September 1, 1996
Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancerA Gadducci, M Ferdeghini, A Fanucchi, et al.
Anticancer Research|March 12, 1998
Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, A Fanucchi, et al.
Anticancer Research|May 6, 1998
The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancerA Gadducci, M Ferdeghini, S Cosio, et al.
Clinical Endocrinology|June 9, 2007
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancerA Iervasi, G Iervasi, M Ferdeghini, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1987
Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patientsO Giampietro, M Ferdeghini, R Miccoli, et al.
Pageof 17